Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 13:10.1038/s41594-025-01582-w.
doi: 10.1038/s41594-025-01582-w. Online ahead of print.

Multiplex and multimodal mapping of variant effects in secreted proteins via MultiSTEP

Affiliations

Multiplex and multimodal mapping of variant effects in secreted proteins via MultiSTEP

Nicholas A Popp et al. Nat Struct Mol Biol. .

Abstract

Despite widespread advances in DNA sequencing, the functional consequences of most genetic variants remain poorly understood. Multiplexed assays of variant effect can measure the function of variants at scale but cannot readily be applied to the ~10% of human genes encoding secreted proteins. Here we develop a flexible, scalable human cell surface display method, multiplexed surface tethering of extracellular proteins (MultiSTEP), to study the consequences of missense variation in coagulation factor IX (FIX), a serine protease in which genetic variation can cause hemophilia B. We combine MultiSTEP with a panel of antibodies to detect FIX secretion and post-translational modification (PTM), measuring 44,816 variant effects for 436 synonymous variants and 8,528 of the 8,759 possible F9 missense variants. Almost half of missense variants impact secretion, PTM or both. We also identify functional constraints on secretion within the signal peptide and for nearly all gain or loss of cysteine variants. Secretion scores correlate strongly with FIX levels in hemophilia B and reveal that loss-of-secretion variants are more often associated with severe disease. Integration of the secretion and PTM scores enables reclassification of 63.1% of F9 variants of uncertain significance in the My Life, Our Future hemophilia genotyping project. Lastly, we show that MultiSTEP can be applied to other secreted proteins, thus demonstrating that MultiSTEP is a multiplexed, multimodal and generalizable method for systematically assessing variant effects in secreted proteins at scale.

PubMed Disclaimer

Conflict of interest statement

Competing interests: J.P.S. was an expert witness for Genentech and Paul, Weiss, Rifkind, Wharton and Garrison. The other authors declare no competing interests.

Update of

Similar articles

Cited by

References

    1. Karczewski KJ et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434–443 (2020). - PMC - PubMed
    1. Richards S et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405–423 (2015). - PMC - PubMed
    1. Fayer S et al. Closing the gap: Systematic integration of multiplexed functional data resolves variants of uncertain significance in BRCA1, TP53, and PTEN. Am. J. Hum. Genet. 108, 2248–2258 (2021). - PMC - PubMed
    1. Tabet D, Parikh V, Mali P, Roth FP & Claussnitzer M Scalable Functional Assays for the Interpretation of Human Genetic Variation. Annu. Rev. Genet. 56, 441–465 (2022). - PubMed
    1. Uhlén M et al. The human secretome. Sci. Signal. 12, (2019). - PubMed

Methods-only references

    1. Gibson DG et al. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat. Methods 6, 343–345 (2009). - PubMed
    1. García-Nafría J, Watson JF & Greger IH IVA cloning: A single-tube universal cloning system exploiting bacterial In Vivo Assembly. Sci. Rep. 6, 1–12 (2016). - PMC - PubMed
    1. den Dunnen JT et al. HGVS recommendations for the description of sequence variants: 2016 update. Hum. Mutat. 37, 564–569 (2016). - PubMed
    1. Miao HZ et al. Bioengineering of coagulation factor VIII for improved secretion. Blood 103, 3412–3419 (2004). - PubMed
    1. Kessler CM et al. B-domain deleted recombinant factor VIII preparations are bioequivalent to a monoclonal antibody purified plasma-derived factor VIII concentrate: a randomized, three-way crossover study. Haemophilia 11, 84–91 (2005). - PubMed

LinkOut - more resources